- Nektar Therapeutics stock price today and history
Nektar Therapeutics (NKTR) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Nektar Therapeutics stock price
Nektar Therapeutics latest news:
Valentine's Day deal is true love for Nektar and Bristol-Myers
The deal limits Bristol-Myers' upfront payments while giving the drugmaker a cut of promising new drug NKTR-214. A new deal between Bristol-Myers Squibb Co. and Nektar Therapeutics (NKTR) came up candy hearts and roses for investors, sending Nektar shares up 12.5% and Bristol-Myers shares up 2.8% in heavy Wednesday trade. The deal is structured in a relatively complex way, effectively serving to limit Bristol-Myers' upfront payments while giving the drugmaker a cut of net profits...
BRIEF-Nektar Therapeutics Says As Of Dec 31, 2017, Had Cash And Investments Of $353.2 Mln
Nektar Therapeutics(NKTR): * NEKTAR THERAPEUTICS SAYS BASED ON PRELIMINARY ESTIMATES, AS OF DEC 31, 2017, COMPANY HAD CASH AND INVESTMENTS OF $353.2 MILLION - SEC FILING Source text: [http://bit.ly/2AJ8qCb] Further company coverage:
BRIEF-Nektar Therapeutics Says Received Notice Of Termination From Daiichi Of Collaboration Agreement
* NEKTAR THERAPEUTICS - ON DEC 6, CO RECEIVED NOTICE OF
TERMINATION FROM DAIICHI OF COLLABORATION AGREEMENT WHICH WILL
BECOME EFFECTIVE AS OF FEB 4, 2018
Why Nektar Therapeutics Shares Delivered a Stupendous 124% in November
Positive news for two drugs in its pipeline sent shares on a tear last month.
Macy's and Hess jump while Bonanza Creek sinks
Macy's, Hess and SandRidge Energy jump while Nektar Therapeutics and Bonanza Creek Energy fall
Neos Therapeutics, Inc.NEOS
Neptune Technologies & Bioresources IncNEPT
Net 1 UEPS Technologies, Inc.UEPS
Net Element, Inc.NETE